Lung anabolic activity in patients with chronic heart failure: Potential implications for clinical practice

Nutrition

Volumn 28, Issue 10, 2012, Pages 1002-1007

  Aquilani, Roberto ^a   La Rovere, Maria Teresa ^a   Febo, Oreste ^a   Baiardi, Paola ^a   Boschi, Federica ^b   Iadarola, Paolo ^b   Viglio, Simona ^b   Dossena, Maurizia ^b   Bongiorno, Andria Innocenza ^b   Pastoris, Ornella ^b   Verri, Manuela ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Bisoprolol; Chronic heart failure; Lung amino acid uptake; Lung anabolism; Pulmonary vascular resistance

Indexed keywords

AMINO ACID; BISOPROLOL; ESSENTIAL AMINO ACID; LEUCINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; LUNG ANABOLISM; LUNG FUNCTION; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AIRWAY REMODELING; AMINO ACIDS; ARTERIES; BISOPROLOL; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; LEUCINE; LUNG; MALE; MIDDLE AGED; PROTEIN BIOSYNTHESIS; VASCULAR RESISTANCE; VEINS;

EID: 84865428499     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.01.003     Document Type: Article

References (34)

1. Fisher A.B. Intermediary metabolism of the lung. Environ Health Perspect 1984, 55:149-158.
2. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003, 65:45-79.
3. Coombe D. Tissue function 1996, Volume I. Harwood Academic Publishers, Amsterdam.
4. Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008, 32:1371-1385.
5. Reid L.M. Vascular remodeling. The pulmonary circulation: normal and abnormal 1990, 259-282. University of Pennsylvania Press, Philadelphia. A.P. Fishman (Ed.).
6. Townsley M.I., Snell K.S., Ivey C.L., Culberson D.E., Liu D.C., Reed R.K., et al. Remodeling of lung interstitium but not resistance vessels in canine pacing-induced heart failure. J Appl Physiol 1999, 87:1823-1830.
7. Delgado J.F., Conde E., Sánchez V., López-Ríos F., Gómez-Sánchez M.A., Escribano P., et al. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 2005, 7:1011-1016.
8. Lowes B.D., Gilbert E.M., Abraham W.T., Minobe W.A., Larrabee P., Ferguson D., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002, 346:1357-1365.
9. Fujio H., Nakamura K., Matsubara H., Kusano K.F., Miyaji K., Nagase S., et al. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Cardiovasc Pharmacol 2006, 47:250-255.
10. Wenzel D., Knies R., Matthey M., Klein A.M., Welschoff J., Stolle V., et al. Beta(2)-adrenoceptor antagonist ICI 118,551 decreases pulmonary vascular tone in mice via a G(i/o) protein/nitric oxide-coupled pathway. Hypertension 2009, 54:157-163.
11. Aquilani R., Opasich C., Gualco A., Verri M., Testa A., Pasini E., et al. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 2008, 10:1127-1135.
12. Aquilani R., Opasich C., Verri M., Boschi F., Febo O., Pasini E., et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol 2003, 42:1218-1223.
13. Thet L.A., Delaney M.D., Gregorio C.A., Massaro D. Protein metabolism by rat lung: influence of fasting, glucose, and insulin. J Appl Physiol 1977, 43:463-467.
14. Romero-Corral A., Lopez-Jimenez F., Sierra-Johnson J., Somers V.K. Differentiating between body fat and lean mass-how should we measure obesity?. Nat Clin Pract Endocrinol Metab 2008, 4:322-323.
15. Plumley D.A., Souba W.W., Hautamaki R.D., Martin T.D., Flynn T.C., Rout W.R., et al. Accelerated lung amino acid release in hyperdynamic septic surgical patients. Arch Surg 1990, 125:57-61.
16. MacLennan P.A., Brown R.A., Rennie M.J. A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett 1987, 215:187-191.
17. Millward D.J., Jepson M.M., Omer A. Muscle glutamine concentration and protein turnover in vivo in malnutrition and in endotoxemia. Metabolism 1989, 38(8 suppl 1):6-13.
18. Rossi D., Pinna G.D., La Rovere M.T., Traversi E. Prognostic significance of tissue-Doppler imaging in chronic heart failure patients on transplant waiting list: a comparative study with right heart catheterization. Eur J Echocardiogr 2011, 12:112-119.
19. Dawson C.A., Roerig D.L., Linehan J.H. Evaluation of endothelial injury in the human lung. Clin Chest Med 1989, 10:13-24.
20. Wagenvoort C.A., Mooi W.J. Congestive vasculopathy. Biopsy pathology of the pulmonary vasculature 1989, 171-198. Chapman and Hall Medical, London. C.A. Wagenvoort, W.J. Mooi (Eds.).
21. Moraes D.L., Colucci W.S., Givertz M.M. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000, 102:1718-1723.
22. Plumley D.A., Austgen T.R., Salloum R.M., Souba W.W. Role of the lungs in maintaining amino acid homeostasis. J Parenter Enteral Nutr 1990, 14:569-573.
23. Martin D.W. Metabolism of purine and pyrimidine nucleotides. Harper's review of biochemistry 1980, 331-348. Lange Book Series, New York. D.W. Martin, P.A. Mayes, V.W. Rodwell (Eds.).
24. Aquilani R., La Rovere M.T., Febo O., Boschi F., Iadarola P., Corbellini D., et al. Preserved muscle protein metabolism in obese patients with chronic heart failure. Int J Cardiol 2011, epub ahead of print.
25. Gacad G., Dickie K., Massaro D. Protein synthesis in lung: influence of starvation on amino acid incorporation into protein. J Appl Physiol 1972, 33:381-384.
26. Shields T.W. Surgical anatomy of the lungs. General thoracic surgery 1972, 55-73. Lea and Febiger, Philadelphia. T.W. Shields (Ed.).
27. Roth E. Immune and cell modulation by amino acids. Clin Nutr 2007, 26:535-544.
28. Cerra F.B., Benitez M.R., Blackburn G.L., Irwin R.S., Jeejeebhoy K., Katz D.P., et al. Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest 1997, 111:769-778.
29. Widlicka A. Enteral nutrition in the cardiothoracic intensive care unit: challenges and considerations. Nutr Clin Pract 2008, 23:510-520.
30. Liu Z., Barrett E.J. Human protein metabolism: its measurement and regulation. Am J Physiol Endocrinol Metab 2002, 283:E1105-E1112.
31. Chen J.M., Levin H.R., Michler R.E., Prusmack C.J., Rose E.A., Aaronson K.D. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 1997, 114:627-634.
32. Delgado J.F., Gómez-Sánchez M.A., Sáenz de la Calzada C., Sánchez V., Escribano P., Hernández-Afonso J., et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant 2001, 20:942-948.
33. Mudge G.H. Strategies to manage the heart failure patient after transplantation. Clin Cardiol 1992, 15(suppl 1):I37-I41.
34. Copeland J.G., Butman S.M., Sethi G. Successful coronary artery bypass grafting for high-risk left main coronary artery atherosclerosis after cardiac transplantation. Ann Thorac Surg 1990, 49:106-110.